| Companies sponsors |
Roche Products (glofitamab) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| Patient carer groups |
Blood Cancer UK |
| |
Lymphoma Action |
| Professional groups |
Association of Cancer Physicians |
| |
Cancer Research UK |
| |
Royal College of Physicians |
| |
Royal College of Radiologists |
| Associated public health groups |
None |
| Comparator companies |
AbbVie (epcoritamab) (confidentiality agreement signed, participating) |
| |
Kite, a Gilead company (axicabtagene ciloleucel) (confidentiality agreement signed, participating) |
| |
Swedish Orphan Biovitrum (loncastuximab tesirine) (confidentiality agreement signed, participating) |
| |
Accord Healthcare (bendamustine, etoposide, gemcitabine, prednisolone, oxaliplatin) (confidentiality agreement not signed, not participating) |
| |
Actavis (bendamustine, etoposide, gemcitabine, prednisolone) (confidentiality agreement not signed, not participating) |
| |
Advanz Pharma (prednisolone) (confidentiality agreement not signed, not participating) |
| |
Aspen (chlorambucil) (confidentiality agreement not signed, not participating) |
| |
Baxter Healthcare (cyclophosphamide, ifosfamide) (confidentiality agreement not signed, not participating) |
| |
Bristol-Myers Squibb Pharmaceuticals (etoposide) (confidentiality agreement not signed, not participating) |
| |
Consilient Health (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Dr Reddy’s Laboratories UK (bendamustine) (confidentiality agreement not signed, not participating) |
| |
Eli Lilly and Company (gemcitabine) (confidentiality agreement not signed, not participating) |
| |
Hospira UK (gemcitabine, oxaliplatin) (confidentiality agreement not signed, not participating) |
| |
Medac UK (bendamustine, etoposide, lomustine, oxaliplatin) (confidentiality agreement not signed, not participating) |
| |
Napp Pharmaceuticals (bendamustine, rituximab) (confidentiality agreement not signed, not participating) |
| |
Pfizer (gemcitabine, vincristine) (confidentiality agreement not signed, not participating) |
| |
Ranbaxy (UK), a Sun Pharmaceutical Company (gemcitabine) (confidentiality agreement not signed, not participating) |
| |
Roche (glofitamab, polatuzumab vedotin, rituximab) (confidentiality agreement not signed, not participating) |
| |
Sandoz (cyclophosphamide, rituximab) (confidentiality agreement not signed, not participating) |
| |
Seacross pharmaceuticals (bendamustine) (confidentiality agreement not signed, not participating) |
| |
Teva Nederland B.V. (bleomycin) (confidentiality agreement not signed, not participating) |
| |
Zentiva (bendamustine, prednisolone) (confidentiality agreement not signed, not participating) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
British National Formulary |
| |
Department of Health – Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
NHS Wales Joint Commissioning Committee |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| Relevant research groups |
Institute of Cancer Research |